JP Morgan Chase
FOLD

JP Morgan Chase’s Amicus Therapeutics FOLD Stock Holding History

JP Morgan Chase’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-33,900
Closed -$399K – 7494
2024
Q1 		$399K Buy
+33,900
New +$434K ﹤0.01% 4946
2021
Q2 		– Sell
-100,000
Closed -$988K – 6420
2021
Q1 		$988K Sell
100,000
-272,500
-73% -$4.22M ﹤0.01% 4241
2020
Q4 		$8.6M Buy
372,500
+32,500
+10% +$665K ﹤0.01% 2335
2020
Q3 		$4.79M Buy
340,000
+318,900
+1,511% +$4.65M ﹤0.01% 2610
2020
Q2 		$318K Hold
21,100
– – ﹤0.01% 4064
2020
Q1 		$195K Sell
21,100
-18,900
-47% -$180K ﹤0.01% 4280
2019
Q4 		$390K Buy
+40,000
New +$366K ﹤0.01% 4365
2019
Q3 		– Sell
-40,000
Closed -$480K – 5804
2019
Q2 		$480K Hold
40,000
– – ﹤0.01% 4264
2019
Q1 		$544K Buy
+40,000
New +$489K ﹤0.01% 4165
2018
Q4 		– Sell
-96,100
Closed -$1.16M – 5752
2018
Q3 		$1.16M Buy
96,100
+56,100
+140% +$785K ﹤0.01% 3817
2018
Q2 		$625K Sell
40,000
-50,000
-56% -$756K ﹤0.01% 4078
2018
Q1 		$1.35M Sell
90,000
-10,000
-10% -$152K ﹤0.01% 3508
2017
Q4 		$1.44M Sell
100,000
-36,000
-26% -$495K ﹤0.01% 3519
2017
Q3 		$2M Buy
+136,000
New +$1.8M ﹤0.01% 3154
2016
Q3 		– Sell
-70,000
Closed -$382K – 4629
2016
Q2 		$382K Sell
70,000
-204,200
-74% -$1.43M ﹤0.01% 3544
2016
Q1 		$2.32M Buy
+274,200
New +$1.94M ﹤0.01% 2622

Other funds holding FOLD

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

JP Morgan Chase's FOLD Position: Q2 2026 in Review

JP Morgan Chase sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 6,749,190 shares — an estimated $97.4M sold.

JP Morgan Chase first reported a position in FOLD in Q2 2013 and held it in 45 quarters. The position peaked at $253M in Q4 2023. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

  • JP Morgan Chase reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
  • JP Morgan Chase sold 6,749,190 Amicus Therapeutics shares in Q2 2026, an estimated $97.4M.
  • JP Morgan Chase first reported a position in Amicus Therapeutics in Q2 2013 and held it in 45 quarters.
  • JP Morgan Chase's Amicus Therapeutics position peaked at $253M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.